360 filings
Page 17 of 18
8-K
jx4cgnf3el rta0ix
27 Feb 07
Dynavax Reports Interim, One-Year Data from Ragweed Allergy Trial at AAAAI
12:00am
8-K
h3i x6cwfqbjl5y85ozp
27 Feb 07
Dynavax Provides 2007 Financial Outlook
12:00am
8-K
7t64uj
14 Feb 07
Dynavax Announces Fourth Quarter and Year End 2006 Financial Results
12:00am
8-K
l9863m6rkwgh c0o
10 Jan 07
Dynavax Reports Interim TOLAMBATM Ragweed Allergy Results from DARTT Trial
12:00am
8-K
77o8ijyi
15 Dec 06
Dynavax Appoints Dr. David M. Lawrence, Kaiser Chairman Emeritus, to Board of Directors
12:00am
8-K
zdp3ww 7cg
7 Dec 06
Other Events
12:00am
8-K
3xw1ws
7 Dec 06
Other Events
12:00am
8-K
9cxk9nc
6 Dec 06
Other Events
12:00am
8-K
eukql
1 Dec 06
Departure of Directors or Principal Officers
12:00am
8-K
zxn 9oso3ts1ldbu
14 Nov 06
Dynavax Reports New Tolamba Data at Acaai Meeting
12:00am
8-K
gbjxstq
3 Nov 06
Dynavax Announces Third Quarter 2006 Financial Results and Updates 2006 Financial Guidance
12:00am
8-K
q89 i7w6m
2 Nov 06
Dynavax Technologies Names Michael Ostrach VP, Chief Business Officer and General Counsel
12:00am
8-K
37nptq8qpe5 a94p2
11 Oct 06
Dynavax Announces Closing of Common Stock Offering and Exercise of Underwriter’s Over-allotment Option
12:00am
8-K
098rl98jn7eciumi96d
4 Oct 06
Dynavax Raises $27 Million In Common Stock Offering
12:00am
8-K
sad ahfbtd4pcjfo2
8 Sep 06
Entry into a Material Definitive Agreement
12:00am
8-K
ae2 u8ubg
31 Aug 06
Dynavax Secures Equity Financing Commitment of Up to $30 Million
12:00am
8-K
w5y7ihnpt3k k15pkba
18 Aug 06
Dynavax Appoints Peggy V. Phillips to Board of Directors
12:00am
8-K
dk0bohtlby6q
28 Jul 06
Dynavax Announces Second Quarter 2006 Financial Results
12:00am
8-K
s5kc12i5
1 May 06
Dynavax Announces First Quarter 2006 Financial Results and Outlook
12:00am
8-K
nrcmq6o6ojg6vdzs
27 Apr 06
Dynavax Closes Acquisition of Rhein Biotech GmbH From Crucell
12:00am